These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 9178834)
1. Purine analogs in the treatment of chronic lymphocytic leukemia. Pott C; Hiddemann W Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834 [TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features. Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527 [TBL] [Abstract][Full Text] [Related]
3. Present status of purine analogs in the therapy of chronic lymphocytic leukemias. Bergmann L Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835 [TBL] [Abstract][Full Text] [Related]
4. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
5. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. Nabhan C; Gartenhaus RB; Tallman MS Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894 [TBL] [Abstract][Full Text] [Related]
6. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia. Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G; Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339 [TBL] [Abstract][Full Text] [Related]
7. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052 [TBL] [Abstract][Full Text] [Related]
12. Is there a place for 2-CDA in the treatment of B-CLL? Mitterbauer M; Hilgenfeld E; Wilfing A; Jäger U; Knauf WU Leukemia; 1997 Apr; 11 Suppl 2():S35-7. PubMed ID: 9178836 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of chronic lymphatic leukemia]. Adam Z; Vorlícek J; Hejlová N Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031 [TBL] [Abstract][Full Text] [Related]
14. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Robak T; Kasznicki M Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433 [TBL] [Abstract][Full Text] [Related]
15. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine? Schirmer M; Michlmayr G; Geisen F; Konwalinka G Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013 [No Abstract] [Full Text] [Related]
16. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland. Robak T Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. Byrd JC; Peterson B; Piro L; Saven A; Vardiman JW; Larson RA; Schiffer C Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. O'Brien S; Kantarjian H; Estey E; Koller C; Robertson B; Beran M; Andreeff M; Pierce S; Keating M N Engl J Med; 1994 Feb; 330(5):319-22. PubMed ID: 7904047 [TBL] [Abstract][Full Text] [Related]
19. Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). Robak T; Jamroziak K; Gora-Tybor J; Stella-Holowiecka B; Konopka L; Ceglarek B; Warzocha K; Seferynska I; Piszcz J; Calbecka M; Kostyra A; Dwilewicz-Trojaczek J; Dmoszyñska A; Zawilska K; Hellmann A; Zdunczyk A; Potoczek S; Piotrowska M; Lewandowski K; Blonski JZ J Clin Oncol; 2010 Apr; 28(11):1863-9. PubMed ID: 20212251 [TBL] [Abstract][Full Text] [Related]
20. New purine analogues for the treatment of chronic B-cell malignancies. Gribbin TE Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]